首页> 中国专利> 一组治疗分裂性人格障碍的中药

一组治疗分裂性人格障碍的中药

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明涉及一组治疗分裂性人格障碍的中药，是按下面各中药质量份比组合而成：柴胡12份、地龙15份、玄参10份、生地10份、生龙骨20份、大黄9份、枳实10份、丹皮10份、桃仁12份、赤芍10份、半夏10份、栀子10份、郁金10份、陈皮10份、甘草7份。发明人以中医学的观点从体质方面分析分裂性人格障碍属于气火交郁、热与血结、腑气不利、痰热上熏，上扰清窍，以通腑泻热、行瘀散结、化痰开窍的中药组合治疗，收到了明显的改良效果。

著录项

公开/公告号CN104998207A

专利类型发明专利
公开/公告日2015-10-28

原文格式PDF
申请/专利权人周振平;
展开▼

申请/专利号CN201510466663.7
发明设计人周振平;李先强;
展开▼

申请日2015-07-31
分类号
代理机构
代理人
地址 535500 广西壮族自治区防城港市上思县思阳镇民政路4-1号嘉俊文具店
入库时间 2023-12-18 11:42:56

法律信息

法律状态公告日

法律状态信息

法律状态
2019-04-05

发明专利申请公布后的视为撤回 IPC(主分类):A61K36/9066 申请公布日:20151028 申请日:20150731

发明专利申请公布后的视为撤回
2016-01-27

实质审查的生效 IPC(主分类):A61K36/9066 申请日:20150731

实质审查的生效
2015-10-28

公开

公开

相似文献

专利
中文文献
外文文献

1. 一组治疗分裂性人格障碍的中药 [P] . 中国专利： CN104998207A . 2015-10-28
2. 用于治疗精神分裂性精神病的脱氧鸭嘴花碱的用途 [P] . 中国专利： CN1886127A . 2006-12-27
3. In view of their capability to antagonize the actions of neurokinins by blocking the neurokinin receptors, and in particular antagonizing the actions of substance P by blocking the NK1 receptor, the compounds according to the invention are useful as a medicine, in particular in the prophylactic and therapeutic treatment of neurokinin-mediated conditions, such as, for instance CNS disorders, in particular depression, anxiety disorders, stress-related disorders, sleep disorders, cognitive disorders, personality disorders, schizoaffective disorders, eating disorders, neurodegenerative diseases, addiction disorders, mood disorders, sexual dysfunction, pain and other CNS-related conditions; inflammation; allergic disorders; emesis; gastrointestinal disorders, in particular irritable bowel syndrome (IBS); skin disorders; vasospastic diseases; fibrosing and collagen diseases; disorders related to immune enhancement or suppression and rheumatic diseases and body weight control. [P] . EA009217B1 . 2007-12-28

机译：考虑到它们通过阻断神经激肽受体来拮抗神经激肽的作用，特别是通过阻断NK1受体来拮抗P物质的作用的能力，根据本发明的化合物可用作药物，特别是在预防和治疗中。治疗神经激肽介导的疾病，例如中枢神经系统疾病，尤其是抑郁症，焦虑症，与压力有关的疾病，睡眠障碍，认知障碍，人格障碍，精神分裂性障碍，进食障碍，神经退行性疾病，成瘾障碍，情绪疾病，性功能障碍，疼痛和其他中枢神经系统相关疾病;炎;过敏性疾病呕吐胃肠道疾病，特别是肠易激综合症（IBS）;皮肤疾病;血管痉挛性疾病;纤维化和胶原蛋白疾病;与免疫增强或抑制，风湿性疾病和体重控制有关的疾病。
4. compound of formula i; pharmaceutical composition; method of treating disorders that are related to or affected by inhibition of norepinephrine reuptake, the 5-ht6 receptor or the 5-ht2a receptor; a method of treating a learning disorder, a cognitive disorder, a memory disorder, a personality disorder, a behavioral disorder, a movement disorder, a neurodegenerative disorder, drug withdrawal disorder, sleep, an eating disorder, acute drug toxicity, a cardiovascular disorder, a sexual dysfunction, a gastrointestinal disorder, a genitourinary disorder, a pain disorder, a nervous disorder or a symptom disorder vasomotor; method of treating alzheimer's disease, attention deficit disorder, schizophrenia, parkinson's disease, tardive dyskinesia, ataxia, bradykinesia, paroxysmal dyskinesias, restless leg syndrome, tremor, essential tremor epilepsy, stroke or head trauma; method of treating coronary artery disease, myocardial infarction, transient ischemic attack, angina, atrial fibrillation, p [P] . BRPI0706523A2 . 2011-01-04

机译：式I化合物;药物组合物;治疗与去甲肾上腺素再摄取，5-ht6受体或5-ht2a受体相关或受其抑制的疾病的方法;一种治疗学习障碍，认知障碍，记忆障碍，人格障碍，行为障碍，运动障碍，神经退行性疾病，戒断药物，睡眠，进食障碍，急性药物毒性，心血管疾病的方法，性功能障碍，胃肠道疾病，泌尿生殖系统疾病，疼痛疾病，神经疾病或症状-血管舒缩;治疗阿尔茨海默氏病，注意力缺陷障碍，精神分裂症，帕金森氏病，迟发性运动障碍，共济失调，运动迟缓，阵发性运动障碍，不安腿综合征，震颤，原发性震颤癫痫，中风或头部外伤的方法;治疗冠状动脉疾病，心肌梗塞，短暂性脑缺血发作，心绞痛，心房颤动，p的方法
5. Quinoclidina substituted aryl Compound Derivative, Pharmaceutical composition useful for treating a disease where this implicated acetylcholine receptor Alpha 7 nicotico,Designed to treat Amyotrophic lateral sclerosis, Personality Disorder, anxiety, depression, dementia, Parkinson's disease. [P] . CL2001002013A1 . 2002-06-21

机译：喹喔啉取代的芳基化合物衍生物，用于治疗牵涉乙酰胆碱受体Alpha 7尼古丁的疾病的药物组合物，设计用于治疗肌萎缩性侧索硬化症，人格障碍，焦虑症，抑郁症，痴呆症，帕金森氏病。